We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Effects of erythropoietin on depressive symptoms and neurocognitive deficits in depression and bipolar disorder.
- Authors
Miskowiak, Kamilla W; Vinberg, Maj; Harmer, Catherine J; Ehrenreich, Hannelore; Knudsen, Gitte M; Macoveanu, Julian; Hansen, Allan R; Paulson, Olaf B; Siebner, Hartwig R; Kessing, Lars V
- Abstract
Depression and bipolar disorder are associated with reduced neural plasticity and deficits in memory, attention and executive function. Drug treatments for these affective disorders have insufficient clinical effects in a large group and fail to reverse cognitive deficits. There is thus a need for more effective treatments which aid cognitive function. Erythropoietin (Epo) is involved in neuroplasticity and is a candidate for future treatment of affective disorders. The investigators have demonstrated that a single dose of Epo improves cognitive function and reduces neurocognitive processing of negative emotional information in healthy and depressed individuals similar to effects seen with conventional antidepressants. The current study adds to the previous findings by investigating whether repeated Epo administration has antidepressant effects in patients with treatment resistant depression and reverses cognitive impairments in these patients and in patients with bipolar disorder in remission.
- Publication
Trials, 2010, Vol 11, p97
- ISSN
1745-6215
- Publication type
Journal Article
- DOI
10.1186/1745-6215-11-97